Delivery Order SPE2DB22D2005-SPE2DB25FJMR6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100 count) on October 8, 2025, with a contract ceiling value of $2,963.92. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 9,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Adderall XR 5 mg capsules (100-count units) with a ceiling value of $1,083.01. This firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively without any set-aside designation. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Adderall XR 20 mg capsules (100 count) with a contract ceiling value of $1,040.94. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,067.34. This competitive award, effective September 19, 2025, with an ultimate completion date of September 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 10 mg capsules in quantities of 100 units, with a contract ceiling value of $1,194.12. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The award supports federal medical procurement needs, with performance of work occurring...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,129.20. The contract, which was competitively awarded without set-aside designation, was finalized on March 11, 2025, with an ultimate completion date of March 12, 2025. The firm fixed price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,670.98. This firm fixed-price delivery order, which is due for completion by September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count) with a ceiling value of $1,104.99 under a firm fixed-price contract type. The award, issued on May 1, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of May 2, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,057.62. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's broader pharmaceutical supply arrangement with the agency. The place of performance is the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJMR6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,755.67. This is a firm fixed-price delivery order with an ultimate completion date of May 22, 2025, representing a short-term pharmaceutical procurement. The award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal medical supply requirements. The place of performance is the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, enabling the company to supply a broad range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. AmerisourceBergen's significant market presence and extensive federal contract portfolio demonstrate the company's critical role in supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/21/25 |